Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Zaidi

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
NPJ Precision Oncology|May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Cancer|December 7, 2021
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instabilityStefania Bellone, Dana M Roque, Eric R Siegel, et al.
Signal Transduction and Targeted Therapy|July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationAlvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervixStefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, et al.
Science (New York, N.Y.)|January 20, 2016
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomaliesJason Homsy, Samir Zaidi, Yufeng Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Integrated mutational landscape analysis of uterine leiomyosarcomasJungmin Choi, Aranzazu Manzano, Weilai Dong, et al.
Nature Genetics|October 10, 2017
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probandsSheng Chih Jin, Jason Homsy, Samir Zaidi, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
NPJ Precision Oncology|May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Cancer|December 7, 2021
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instabilityStefania Bellone, Dana M Roque, Eric R Siegel, et al.
Signal Transduction and Targeted Therapy|July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationAlvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervixStefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, et al.
Science (New York, N.Y.)|January 20, 2016
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomaliesJason Homsy, Samir Zaidi, Yufeng Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Integrated mutational landscape analysis of uterine leiomyosarcomasJungmin Choi, Aranzazu Manzano, Weilai Dong, et al.
Nature Genetics|October 10, 2017
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probandsSheng Chih Jin, Jason Homsy, Samir Zaidi, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Pageof 5